Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

ENXTPA:GLE
ENXTPA:GLEBanks

Is Société Générale (ENXTPA:GLE) Balancing Buybacks and New Debt to Quietly Redefine Its Capital Playbook?

In late January 2026, Société Générale Société anonyme completed two €30,000,000 fixed-income offerings of callable senior unsecured notes and reported that its €1.00 billion share buy-back program was over 95% executed. This combination of bond issuance and substantial capital return highlights how the bank is actively managing its balance sheet while reducing its share count. We will now examine how the near-completion of the €1.00 billion share buy-back shapes Société Générale’s broader...
TSX:LUN
TSX:LUNMetals and Mining

Did Record 2025 Output and New Copper-Gold Guidance Just Shift Lundin Mining's (TSX:LUN) Investment Narrative?

In January 2026, Lundin Mining Corporation reported record 2025 copper and gold production alongside new multi-year production guidance, and indicated that its fourth-quarter 2025 revenue would be boosted by approximately $83 million in pre-tax provisional pricing adjustments on prior period copper and gold concentrate sales. These updates give investors greater visibility into Lundin Mining’s recent operating performance and planned production levels across copper and gold through...
NasdaqGM:SGMT
NasdaqGM:SGMTBiotechs

Why Sagimet Biosciences (SGMT) Is Up 7.7% After Denifanstat’s Phase 3 Acne Success And What's Next

Sagimet Biosciences recently reported that Ascletis Pharma’s Phase 3 trial of ASC40 (Denifanstat) for acne met all primary and secondary endpoints and was well-tolerated, with no serious adverse events observed. The results highlight fatty acid synthase (FASN) inhibition as a potentially new way to treat acne, with findings slated for presentation at upcoming medical congresses and in scientific publications. Next, we’ll examine how Denifanstat’s Phase 3 success in acne may influence Sagimet...
NYSE:UAA
NYSE:UAALuxury

Is Under Armour (UAA) A Recovery Story After Recent Share Price Rebound?

This article walks through key signals you can use to assess whether Under Armour at around US$6.24 might be a bargain or a value trap. The stock is up 18.0% over the last month and 18.0% year to date, while the 1-year return of negative 24.4% and 3- and 5-year returns of negative 48.9% and negative 69.9% highlight a much tougher longer-term picture. Recent attention on Under Armour has focused on how the brand fits into an increasingly competitive athletic apparel market and what that could...
TSX:EQB
TSX:EQBBanks

3 TSX Stocks That May Be Undervalued In February 2026

As the Canadian market experiences robust earnings growth, with fourth-quarter results showing a solid 12.3% year-over-year increase for the TSX, investors are keeping a close eye on potential opportunities amidst this positive momentum. In this environment, identifying undervalued stocks can be particularly rewarding, as they may offer significant upside potential when market conditions align favorably with their intrinsic value.
TSXV:TLT
TSXV:TLTMedical Equipment

TSX Penny Stock Spotlight: Fox River Resources And Two Others To Consider

As the TSX embarks on a solid start to the earnings season, with expectations of broad-based profit growth across sectors, investors are eyeing opportunities in various corners of the market. Penny stocks, often associated with smaller or newer companies, continue to capture interest due to their potential for growth at accessible price points. By focusing on those with robust financials and clear growth prospects, these stocks can offer both stability and upside potential.
TSX:TCL.A
TSX:TCL.APackaging

3 TSX Dividend Stocks To Consider With Up To 4.7% Yield

As the TSX kicks off its fourth-quarter earnings season with promising results, investors are keenly observing how the Canadian market's robust profit growth might influence broader market leadership. In this context, dividend stocks offer a compelling option for those seeking stable income and potential capital appreciation amidst evolving economic conditions.
SGX:A7RU
SGX:A7RUChemicals

Keppel Infrastructure Trust (SGX:A7RU) Margin Improvement Tests Bullish Income Narrative

Keppel Infrastructure Trust (SGX:A7RU) has released its FY 2025 numbers with second half revenue of S$1.2b and basic EPS of S$0.0054, alongside trailing 12 month revenue of S$2.3b and EPS of S$0.0153 that sit against a reported 51.2% earnings growth over the last year. The trust has seen revenue move from S$1.2b in 2H 2024 to S$1.2b in 2H 2025, while basic EPS shifted from S$0.0144 to S$0.0054 over the same halves. This sets up a story where higher net margins of 4.1% on a trailing basis and...
NasdaqGS:WTFC
NasdaqGS:WTFCBanks

Is Wintrust Financial (WTFC) Still Attractive After Strong Multi‑Year Share Price Gains

If you are wondering whether Wintrust Financial's recent share price leaves much upside on the table, it starts with understanding what the current market price is really implying about the bank's long term prospects. The stock last closed at US$156.04, with returns of 7.3% over the past week, 9.4% over the past month, 9.4% year to date and 22.8% over the past year. The 3 year and 5 year returns sit at 72.2% and 149.7% respectively. These returns have helped put Wintrust Financial on the...
NYSE:USB
NYSE:USBBanks

Is It Too Late To Consider U.S. Bancorp (USB) After Its Strong 1-Year Share Price Run?

If you are wondering whether U.S. Bancorp's share price still offers value after a solid run, this article walks through what the current market price could be implying about the business. With the stock last closing at US$58.69, U.S. Bancorp has recorded returns of 3.8% over 7 days, 8.8% over 30 days, 8.8% year to date, 29.1% over 1 year, 36.3% over 3 years, and 52.7% over 5 years. Recent coverage of large U.S. banks has focused on how they are positioned under current interest rate...
BIT:AVIO
BIT:AVIOAerospace & Defense

The Bull Case For Avio (BIT:AVIO) Could Change Following Upgraded 2025 Backlog And Revenue Guidance – Learn Why

Avio S.p.A. recently upgraded its guidance for FY 2025 order backlog and net revenues, citing a substantial wave of Q4 orders and faster-than-planned execution. Management highlighted that this stronger-than-expected order intake underpins confidence in the company’s ability to convert commercial momentum into longer-term value for shareholders. We will now examine how Avio’s upgraded order backlog expectations may reshape its investment narrative and future growth profile. Find companies...
ENXTAM:UMG
ENXTAM:UMGEntertainment

Is Universal Music Group (ENXTAM:UMG) Turning Cultural Dominance Into Durable Global Moat Through China Deal?

Universal Music Group has recently gained broad attention as its artists dominated the past 68th Annual Grammy Awards and it expanded its global footprint through a multi-year licensing deal with NetEase Cloud Music in China. Together with higher-profile sustainability initiatives and new media projects that showcase its archives, these developments highlight how UMG is leveraging both cultural influence and distribution reach across key markets. Next, we’ll consider what these moves,...
SGX:C09
SGX:C09Real Estate

How Strong Newport Residences Launch Sales At City Developments (SGX:C09) Has Changed Its Investment Story

City Developments Limited recently reported that 57% of units at its newly launched Newport Residences freehold project were sold quickly, with 139 of 246 units taken up and sea-facing two-bedroom apartments fully booked, underscoring firm buyer interest in this central business district location near the Greater Southern Waterfront. This strong take-up, ahead of the company’s unaudited full-year 2025 results due on February 27, puts additional focus on how its project pipeline, margins, and...